$PSTV Analysts will need to update their predictions in next couple of days. There are new data that needs to be calculated in. That changes a picture quite a lot. 1. Enough cash to go forward, nondilutive funding and they try to avoid public offering decreases risk. Adds around 40-50% to price target due to the discounted risk. 2. RNL Phase 1 cohort 5/6 safety data reduces risk of phase 1 success around 60%. 3. Partnership discussions reduces capital risk. Unknown % but adds positive factor. 4. Possibility to go straight to phase 3 increases chances of trial success around 450%. Right now goes to positive factor list and is not counted or if counted then small %. So news that will get PSTV straight to the moon are partnership or phase 1 straight to phase 3 news. Also if they succeed with nondilutive funding we will see 100%+ day as this decreases risk of public offering. Depends on sum, but the risk can go 0.